Massachusetts wanted to exclude some drugs from coverage under its Medicaid program — a common negotiating tactic for private insurers looking to avoid paying for costly therapies. The Trump administration decided that the proposal goes too far, handing the pharmaceutical industry a win.

from Kaiser Health News https://ift.tt/2tSi0BB

0 comments:

Post a Comment

Popular Posts